ACTUATE THERAPEUTICS, INC.
Calidad de datos: 83%
ACTU
Nasdaq
Manufacturing
Chemicals
$1.86
▼
$0.07
(-3.39%)
Cap. Mercado: 43.99 M
Precio
$1.86
Cap. Mercado
43.99 M
Rango del Día
$1.77 — $1.94
Rango de 52 Semanas
$1.77 — $11.99
Volumen
77,585
Apertura $1.94
Promedio 50D / 200D
$3.55
47.73% below
Promedio 50D / 200D
$6.08
69.50% below
Quick Summary
Puntos Clave
Negative free cash flow of -19.21 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-536.74%
Below sector avg (-53.41%)
ROIC-390.17%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio2.74
Interest Coverage-1110.88
Valoración
PE (TTM)
-1.98
Below sector avg (-1.48)
P/B Ratio4.02
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -2.0 | -1.5 |
| P/B | 4.0 | 1.6 |
| ROE % | -536.7 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -22.23 M |
| ROE | -536.74% | ROA | -180.11% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -19.21 M |
| ROIC | -390.17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.74 |
| Interest Coverage | -1110.88 | Asset Turnover | N/A |
| Working Capital | 11.07 M | Tangible Book Value | 10.94 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.98 | Forward P/E | N/A |
| P/B Ratio | 4.02 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -43.67% | ||
| Market Cap | 43.99 M | Enterprise Value | 27.06 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.06 | Revenue / Share | N/A |
| FCF / Share | -0.81 | OCF / Share | -0.81 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 86.41% |
| SBC-Adj. FCF | -23.95 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | — | — |
| Net Income | -22.23 M | -27.29 M |
| EPS (Diluted) | -1.06 | -3.26 |
| Gross Profit | — | — |
| Operating Income | -22.50 M | -25.16 M |
| EBITDA | — | — |
| R&D Expenses | 10.29 M | 18.68 M |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | 20,250.0 | 18,717.0 |
| Income Tax | 800.0 | 800.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 14.04 M | 9.32 M |
| Total Liabilities | 6.11 M | 9.21 M |
| Shareholders' Equity | 7.92 M | 104,186.0 |
| Total Debt | — | — |
| Cash & Equivalents | 13.16 M | 8.64 M |
| Current Assets | 13.64 M | 9.21 M |
| Current Liabilities | 5.71 M | 8.80 M |
{"event":"ticker_viewed","properties":{"ticker":"ACTU","listing_kind":"stock","pathname":"/stocks/actu","exchange":"Nasdaq","country":"US"}}